Letter Written in Response to van Bon et al.: “Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial”

Podobne zapisy

• Siphon Effects on Continuous Subcutaneous Insulin Infusion Pump Delivery Performance
  od: Zisser, Howard C., i wsp.
  Wydane: (2010)
• Compatibility of Insulin Lispro, Aspart, and Glulisine with the Solo™ MicroPump, a Novel Miniature Insulin Pump
  od: Senesh, Gil, i wsp.
  Wydane: (2010)
• Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO‐Pump‐2
  od: Warren, Mark, i wsp.
  Wydane: (2021)
• Insulin Infusion Set: The Achilles Heel of Continuous Subcutaneous Insulin Infusion
  od: Heinemann, Lutz, i wsp.
  Wydane: (2012)
• Continuous subcutaneous insulin infusion: practical issues
  od: Banshi D Saboo, i wsp.
  Wydane: (2012-01-01)